BridgeMD
LIC-block with Lidocaine or Ropivacaine for closed reduction of wrist fracture
EU CTIS ID: 2024-510572-20-00
What this study is testing
To investigate the feasibility of the lateral infraclavicular plexus brachialis (LIC) block for acute closed reduction of distal radius fractures, we will compare the pain-relieving and muscle-relaxing properties of the LIC block with short- and long-acting local anesthetics in different concentrations but at the same volume. In addition to motor and sensory blockade during repositioning, feasibility will also be assessed by other patient-related and block-related factors, as well as by factors related to the repositioning and plastering procedure.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients having a distal radius fracture requiring closed reduction
You likely can't join if
- BMI > 40 kg/m2
- Weight < 50 kg
- Age < 18 years
- ASA physical status classification system grade >3
- Allergy to experimental drugs
- Patients who cannot cooperate with the examinations or treatment
See the full eligibility criteria
- Patients having a distal radius fracture requiring closed reduction
- BMI > 40 kg/m2
- Weight < 50 kg
- Age < 18 years
- ASA physical status classification system grade >3
- Allergy to experimental drugs
- Patients who cannot cooperate with the examinations or treatment
- Patients who do not understand or speak Danish or English
- Patients with peripheral or central neurological disease or nerve damage with neurological effect on the upper extremity, where closed reduction is required
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.